Last Updated on
Divya Coronil Tablet Covid-19 Launch: Yoga guru Baba Ramdev will launch a medicine to treat Covid-19 today. The results of the clinical trial of Patanjali Ayurveda drug ‘Divya Coronil Tablet’ on Covid-19 patients will be announced today by Yoga Guru Baba Ramdev and Acharya Balakrishna at Patanjali Yogpeeth Haridwar.
According to Patanjali Yogpeeth, this research on corona tablets is the result of the joint efforts of Patanjali Research Institute Haridwar and National Institute of Medical Science Jaipur. The drug is being manufactured at Divya Pharmacy and Patanjali Ayurved Limited Haridwar. During this time, teams of scientists, researchers, and doctors will also be present.
A few days ago, Acharya Balakrishna claimed that after five months of research at and several rounds of successful trials on mice, the Patanjali Research Institute has been successful in formulating Ayurvedic medicine for Covid-19. The clinical case study required for this has been completed, while the clinical control trial is in its final stages.
According to Acharya Balakrishna, the medicine contains Ashwagandha, Giloy, Tulsi, Shvasari juice, and Anu oil. This medicine is authenticated from all major institutions, journals, etc., nationally and internationally, depending on its use, treatment, and effect. This research study on this medicine has also been published in the International Journal of Biomedicine Pharmacotherapy of America.
Currently, three drugs – Ciprimi, Fabiflu, and Covifor – are mainly used to treat corona in the country. Ciprimi and Covifor are generic versions of the antiviral drug remdesivir.
According to Acharya Balakrishna, Ashwagandha included in Divya Coronil Tablet does not allow Covid-19’s RBD to meet ACE of the human body. Due to this, healthy cells cannot enter the infected human body.